The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)
Open accessAbstract
Background: Drug induced anaphylaxis is a well-known adverse drug reaction for some drug classes, but emerging drug causes of anaphylaxis and novel mechanisms may contribute in unrecognized ways. Objective: We sought to determine the top drugs reported in association with anaphylaxis and anaphylaxis followed by death in the FDA Adverse Event Reporting System (FAERS). Methods: We reviewed the publicly available FAERS database from 1999-2019. Using search terms “anaphylactic shock” or “anaphylactic reaction” and sorting cases by generic drug names, we counted and trended reports to FAERS in which a drug was associated with anaphylaxis or anaphylaxis followed by death. Results: From 1999-2019, there were 17,506,002 adverse drug events reported in FAERS, of which 47,496 (0.27%) were reported as anaphylaxis. Excluding patients without age, sex, or country data, respectively, the median age of patients in reports of anaphylaxis was 52 [IQR: 28], 62.71% were female, and 13,899/34,381 (40.43%) reports were from the US. There were 2,984/47,496 (6.28%) reports of anaphylaxis followed by death. Top drug classes associated with anaphylaxis in FAERS were antibiotics, monoclonal antibodies (mAbs), NSAIDs and acetaminophen. Top drug classes associated with anaphylaxis deaths were antibiotics, radiocontrast agents and intraoperative agents. Linear regression demonstrated reports of anaphylaxis to mAbs increasing at an average rate of 0.77 percent of total anaphylaxis reports per year (95% CI: 0.65, 0.88)from 2.00% in 1999 to 17.37% in 2019, faster than any other drug class. Conclusion: Antibiotics were highly reported for anaphylaxis overall and anaphylaxis followed by death. Increasing reports were noted for anaphylaxis to monoclonal antibody therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Cited by
Wu, T., Zhang, Y., Shi, Y., Yu, K., Zhao, M., Liu, S., & Zhao, Z. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01202-1 · Cited by 38
Huang, L., Shi, Z., Tang, F., & Wang, H. (2026) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2025.3590149 · Cited by 2
Metadata
- Authors
- Yu, R. J., Krantz, M. S., Phillips, E. J., & Stone, C. A.
- Venue
- The Journal of Allergy and Clinical Immunology: In Practice
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 9
- Issue
- 2
- Pages
- 819-829.e2
- ISSN
- 2213-2198 (ISSN-L)
- OpenAlex
- W3088121765
- Cited by
- 222
- References
- 1
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS). https://app.cochat.ai/papers/10.1016/j.jaip.2020.09.021
- The paper
- Yu, R. J., Krantz, M. S., Phillips, E. J., & Stone, C. A. (2021). Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS). The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2020.09.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.